CD8A and neoplasm: Low numbers of tumor-infiltrating cytotoxic CD8+ T cells before treatment were significantly correlated with poor outcome after RCT in several studies [50–53] but the role of CTLA-4 or PD-1/PD-L1 as negative regulators of CD8+ T cell activation has not been addressed.